Connect your AI

Evolus EOLS Common stock, capital shares reserved for future issuance

Common stock, capital shares reserved for future issuance at other companies

PepsiCoPEP

89M-6.3%

Mondelez InternationalMDLZ

68.1M-5.3%

Bank of AmericaBAC

498M+5.5%

PNC Financial ServicesPNC

77M-1.3%

Wells Fargo & CompanyWFC

$203.11M-12.9%

Rockwell AutomationROK

10.6M-13.1%

Other financials

Income statement

Revenue$73.1M+6.7%

Gross profit$48.9M+4.8%

Operating income-$6.8M+54.9%

Net income-$10.7M+43.5%

EPS (diluted)-$0.16+46.7%

Balance sheet

Cash & equivalents$49.8M-26.7%

Total debt$164.9M-4.1%

Total equity-$28.8M-336%

Total assets$220.6M+3.4%

Cash flow

Operating cash flow-$10.0M+36.3%

CapEx$415.0K+30.1%

Free cash flow-$10.4M+35.0%

Valuation

Market cap$470.86M-21.3%

Enterprise value$585.97M-16.6%

P/S1.6×-0.6×

Profitability

Gross margin66.1%-2.4pp

Operating margin-13.7%-1.9pp

Net margin-14.4%-3.3pp

FCF margin-9.6%-3.6pp

Returns & leverage

Return on equity-472.6%-1,534pp

Debt / equity22.2×—

Current ratio2×-0.3×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's common stock, capital shares reserved for future issuance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Evolus's common stock, capital shares reserved for future issuance?: Evolus (EOLS) reported common stock, capital shares reserved for future issuance of $795.78K in Q1 2026.
How has Evolus's common stock, capital shares reserved for future issuance changed year-over-year?: Evolus's common stock, capital shares reserved for future issuance decreased by 54.2% year-over-year, from $1.74M to $795.78K.